Metastatic Salivary Duct Carcinoma with ERBB2 Amplification and Sequential Response to Ado-Trastuzumab Emtansine and Neratinib: A Case Report

INTRODUCTION: Salivary duct carcinoma (SDC) is an aggressive and rare subtype of salivary gland carcinoma. Surgical excision and radiotherapy are standard of care for early cancer. Chemotherapies with taxanes and platinum show overall response rates between 39% and 50%. SDCs are often associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Asper, Nora, Roth, Kersten Sven, Hany, Thomas Frank, Salzberg, Sacha Pierre, Tinguely, Marianne, Kadvany, Yannick, Trojan, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686627/
https://www.ncbi.nlm.nih.gov/pubmed/38033416
http://dx.doi.org/10.1159/000535097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686627/
https://www.ncbi.nlm.nih.gov/pubmed/38033416
http://dx.doi.org/10.1159/000535097

Ejemplares similares